A 69-year-old woman with a history of relapsed acute lymphocytic leukemia presented for “evaluation of a diffuse, asymptomatic scaly rash appearing 15 days after initiating inotuzumab ozogamicin 0.5 mg/m2 infusions and ponatinib 45 mg daily.” This case provides 3 questions with possible answers regarding diagnosis, adverse effects, and next steps for management.
Learn more at the Journal of the American Academy of Dermatology Case Reports.